Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia;Klinik und pathobiologie von dysplasien bei chronisch-entzündlichen darmerkrankungen: Aktuelle empfehlungen zur dysplasieüberwachung

Zeitschrift fur Gastroenterologie

Volumn 39, Issue 10, 2001, Pages 861-875

  Raithel, M ^a   Weidenhiller, M ^a   Schwab, D ^a   Muller S ^a   Hahn, E G ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Carcinoma Surveillance; Crohn's Disease; Dysplasia; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER;

CANCER RISK; CHRONIC DISEASE; COLON RESECTION; COLORECTAL CARCINOMA; CROHN DISEASE; DYSPLASIA; ENDOSCOPY; ENTERITIS; GASTROINTESTINAL BIOPSY; HISTOPATHOLOGY; HUMAN; MUCINOUS CARCINOMA; PATHOGENESIS; RECTUM CARCINOMA; REVIEW; SENSITIVITY AND SPECIFICITY; SIGMOID CARCINOMA; SIGNET RING CARCINOMA; TREATMENT INDICATION; ULCERATIVE COLITIS;

ADENOCARCINOMA, MUCINOUS; CELL TRANSFORMATION, NEOPLASTIC; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; CROHN DISEASE; FOLLOW-UP STUDIES; HUMANS; INTESTINAL MUCOSA; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY;

EID: 0034758684     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17870     Document Type: Review

References (88)

1. Cancer surveillance in ulcerative colitis - A time for reappraisal
2. Colon cancer in ulcerative colitis
3. Chronic ulcerative colitis associated with malignant disease
4. Crohn's disease and cancer
5. Diagnostik und Therapie der Colitis ulcerosa - Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft for Verdauungs- und Stoffwechselerkrankungen
6. Cancer in inflammatory bowel disease
7. Primary sclerosing cholangitis in ulcerative Colitis - A risk factor for the development of dysplasia and DNA aneuploidy?
8. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis
9. ALMs versus DALMs in ulcerative colitis: Polypectomy or colectomy
10. Colon cancer surveillance
11. Cancer in inflammatory bowel disease
12. Prophylactic colectomy or surveillance of chronic ulcerative colitis? A decision analysis
13. Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis
14. Mindert antientzündliche Therapie das Karzinomrisiko bei CED?
15. Carcinoma of the intestinal tract in Crohn's disease: Results of a survey conducted by the National Foundation for Ileitis and Colitis
16. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement
17. Gastrointestinal complications of ulcerative colitis and Crohn's disease
18. Mucosal dysplasia in inflammatory bowel disease
19. Inflammatory bowel disease
20. The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: A comparative immunhistochemical study
21. Precancer and cancer inextensive ulcerative colitis: Findings among 401 patients over 22 years
22. Colorectal cancer prevention in ulcerative colitis: A case control study
23. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
24. Cancer surveillance in ulceratice colitis
25. Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps
26. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis
27. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangits
28. Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis
29. Crohn's disease and intestinal carcinoma
30. Rectal mucosal dysplasia in Crohn's disease
31. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical implications
32. Sialysyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: A retrospective case-control study
33. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis
34. Small intestine adenocarcinoma complicating regional enteritis
35. The risk of cancer in Crohn's disease
36. Crohn's disease and colorectal carcinoma: Rectal cancer complicating long-standing active perianal disease
37. Early presentation of carcinoma of the small bowel in Crohn's disease
38. Malignant colorectal strictures in Crohn's disease
39. Definition und klinische Bedeutung der Dysplasie im Verdauungstrakt
40. DNA aneuploidy in Crohn's disease and ulcerative colitis: Results of a comparative flow cytometric study
41. p53 expression in ulcerative colitis: A longitudinal study
42. Karzinome bei chronisch entzündlichen Darmerkrankungen
43. Kolorektales Karzinomrisiko bei Colitis ulcerosa - Überwachungsstrategien und Identifikation von Risikoptienten
44. Dysplasia-associated lesion of mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy
45. Density gradient centrifugation of colonic fluid after segmental lavage: A method of purification of exfoliative epithelial colonic cells for cytological interpretation and image cytometry in patients with long-standing ulcerative colitis
46. Diamine oxidase activities in the large bowel mucosa of ulcerative colitis patients
47. Tissue carcinoembryonic antigen and DNA aneuploidy in precancerous and cancerous colorectal lesions
48. Frequent mutations of the E2F-4 cell cycle gene in primary human gastrointestinal tumors
49. Search for a specific marker of mucosal dysplasia in chronic ulcerative colitis
50. Mast cell-tumor cell interactions: For or against tumour growth and metastasis?
51. Evidence of mast-cell histamine being mitogenic in intact tissue
52. Promotion of colorectal neoplasia in experimental murine ulcerative colitis
53. Large bowel tumor promotion by inhibition of mucosal diamine oxidase in rats II
54. N-methyl-N-formylhydrazine: A toxic and mutagenic inhibitor of intestinal diamine oxidase
55. Human intestinal diamine oxidase (DAO) acticity in Crohn's disease: A new marker for disease assessment?
56. The start of a programme for measuring diamine oxidase activity in biopsy specimens of human rectal mucosa
57. Measurement of gut diamine oxidase activity: Diamine oxidase as a new biologic marker of colorectal proliferation?
58. Fecal bile acids, dysplasia, and carcinoma in ulcerative colitis
59. Association of fecal bile acids and colon cancer in ulceratice colitis
60. Association of fecal bile acids and colon cancer in ulcerative colitis
61. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis
62. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis
63. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia
64. Sialosyl-Tn antigen (s-Tn) in non-dysplastic biopsies may predict development of cancer or dysplasia in ulcerative colitis
65. Aneuploidy in ulcerative colitis; reproducibility, topographic distribution, and relation to dysplasia
66. DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis
67. Expression of the carcinoma associated antigen CA 19-9 and CA50 in inflammatory bowel disease
68. Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9
69. Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis or colorectal adenomas
70. 5-Aminolevulinic acid-induced protoporphyrin IX for the detection of gastrointestinal dysplasia
71. Fluorescence endoscopy in gastroenterology
72. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis
73. Ulcerative colitis and colonic cancer: Problems in assessing the diagnostic usefulness of mucosal dysplasia
74. Colorectal cancer in patients with ulcerative colitis
75. Colonoscopic diagnosis of dysplasia and early cancer in long-standing colitis
76. Surveillance in the routine management of ulcerative colitis: The predictive value of low-grade dysplasia for cancer
77. Vorsorge zur Prävention oder Früherkennung des kolorektalen Karzinoms
78. The pathology and politics of dysplasia in ulcerative colitis
79. Therapie des Morbus Crohn - Ergebnisse einer Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten
80. The natural history of ulcerative colitis
81. Colonoscopy and biopsy
82. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis
83. Pouchitis and neoplasia in the pelvic ileal reservoir
84. Twenty years colonoscopic surveillance of patients with ulcerative colitis
85. Photodynamic diagnosis (PDD) of dysplasia in ulcerative colitis after sensitization with 5-aminolevulinic acid (ALA)
86. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?